Navigation Links
Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
Date:4/15/2008

Sciences of the United States of America (PNAS) in the edition published on April 15, 2008.

About Genmab A/S

Genmab is a leading international biotechnology company focused on developing fully human antibody therapeutics for unmet medical needs. Using cutting-edge antibody technology, Genmab's world class discovery, development and manufacturing teams have created and developed an extensive pipeline of products for potential treatment of a variety of diseases including cancer and autoimmune disorders. As Genmab advances towards a commercial future, we remain committed to our primary goal of improving the lives of patients who are in urgent need of new treatment options. For more information on Genmab's products and technology, visit http://www.genmab.com.

This press release contains forward looking statements. The words "believe", "expect", "anticipate", "intend" and "plan" and similar expressions identify forward looking statements. Actual results or performance may differ materially from any future results or performance expressed or implied by such statements. The important factors that could cause our actual results or performance to differ materially include, among others, risks associated with product discovery and development, uncertainties related to the outcome and conduct of clinical trials including unforeseen safety issues, uncertainties related to product manufacturing, the lack of market acceptance of our products, our inability to manage growth, the competitive environment in relation to our business area and markets, our inability to attract and retain suitably qualified personnel, the unenforceability or lack of protection of our patents and proprietary rights, our relationships with affiliated entities, changes and developments in technology which may render our products obsolete, and other factors. Genmab is not under an obligation to up-date statements regarding the future fo
'/>"/>

SOURCE Genmab A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DAHANCA Initiates Head and Neck Cancer Study With Genmabs HuMax-EGFr
2. Bionomics Achieves US$1 Million Milestone Payment from Genmab
3. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
4. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
5. Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Companys Anthrax Therapeutic
6. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
7. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity
8. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
9. Female Health Company Receives Brazilian Order: Four Million FC Female Condoms
10. The Pittsburgh Life Sciences Greenhouse Relocates Therapeutics Company to Pittsburgh
11. Chimerix Initiates a Multi-dose Clinical Trial of the Companys Lead Compound, CMX001, for the Treatment for Smallpox Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... Sept. 3, 2015  Ascendis Pharma A/S ... biotechnology company that applies its innovative TransCon ... today announced plans to present at several ... Healthcare Conference in BostonDate: , Thursday, September ... of America Merrill Lynch Global Healthcare Conference ...
(Date:9/3/2015)... Research and Markets ( http://www.researchandmarkets.com/research/twqfk6/global_medical ) has ... Packaging Market - By Packaging type, Regions and Vendors ... report to their offering. The growth ... its end use industry, i.e., Medical devices industry. More ... devices so as to be tamper evident, and child-resistant. ...
(Date:9/3/2015)... 2015 , Novel ideas ... High need for translation of findings into ... of life   , On occasion of ... ® , young scientists from across Europe ... novel ideas with potential for achieving major advances in pain management. ...
Breaking Medicine Technology:Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 2Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 3Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 4Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 5Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 6Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 7Global Medical Devices Packaging Market 2015 - Market Trends and Forecasts to 2020 for the $21 Billion Industry 8Results of Pain Research Projects Raise Aspiration for Advanced Pain Treatment 2Results of Pain Research Projects Raise Aspiration for Advanced Pain Treatment 3Results of Pain Research Projects Raise Aspiration for Advanced Pain Treatment 4Results of Pain Research Projects Raise Aspiration for Advanced Pain Treatment 5
... SAN FRANCISCO, Calif., Jan. 9 Rigel,Pharmaceuticals, Inc. ... has begun,enrolling patients in a Phase 1 study ... orally available, potent inhibitor of Janus Kinase,3 (JAK3), ... arthritis,(RA), psoriasis and other immune disorders. In preclinical ...
... INDIANAPOLIS, Jan. 9 Semafore Pharmaceuticals Inc.,today ... Research (2008; Vol. 68,Issue 1: 206-215) reports ... antitumor and antiangiogenic activity., The paper, ... Prodrug, SF1126, with Antitumor and Antiangiogenic Activity," ...
Cached Medicine Technology:Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders 2Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders 3Semafore's SF1126 Exhibits Antitumor and Antiangiogenic Activity 2
(Date:9/4/2015)... Dallas, Texas (PRWEB) , ... September 04, 2015 ... ... the recipient of three separate “Partner of the Year” awards at this year’s ... included being named Microsoft’s 2015 “Partner of the Year” Award Winner for Data ...
(Date:9/4/2015)... ... ... consumers are looking for a quick and convenient way to produce a hot remedy for ... provide a quick and simple way to brew a hot cup of cold remedy when ... result, they enhance comfort and health. The invention features a novel design that is lightweight, ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... and development of its first neighborhood created specifically for adults with intellectual, developmental ... the Phoenix Metro area and feature 30 cottage or “pocket” homes. In this ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... products, has a Labor Day offer that cannot be passed up. FiltersFast.com, ... up on necessary air and water filtration product replacements. Take advantage of this ...
(Date:9/3/2015)... ... September 03, 2015 , ... Allied Anesthesia is proud to announce ... the norm not the exception. , St. Jude was recently named one of the ... Association, making it one of only 10 hospitals in the state to earn the ...
Breaking Medicine News(10 mins):Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 2Health News:Allied Anesthesia Physicians Announce Partnership with St. Jude 3
... , , ... and a global leader in the development and delivery of customizable ... be showcasing recent enhancements to Ovid Universal Search, our first-to-market cross-platform ... on the American Psychological Association,s (APA,s) Thesaurus of Psychological Index ...
... PHOENIX, Dec. 1 Abrazo Media Relations-- The Center for ... Mesa, Arizona announces the addition of orthopaedic surgeon Dr. J. ... trained in sports medicine and orthopaedic surgery after recently completing ... he focused on adult and pediatric orthopaedic sports medicine. He ...
... 30 November 2009. Performing surgical operations without leaving ... become a reality. This is demonstrated by the recent ... Surgery), an innovative surgical approach that allows surgical access ... advantageous for the patient: lack of scars, shorter hospital ...
... to successfully obtain information about the cost of medical ... improve price transparency, according to a new study. ... from less than one-third of the hospitals they approached ... those allowed under California law, according to the findings ...
... to academic achievement, study finds , TUESDAY, Dec.1 (HealthDay ... may boost brainpower, making for better school grades and ... , Given that most doctors and laypeople know (or ... on healthy bodies, the authors of a new study, ...
... ADDISON, Texas, Dec. 1 For many employers, the issue ... an employee benefit, it,s providing for the needs of their ... effort, with the help of Concentra, by opening a worksite ... and convenient health care services directly to employees and their ...
Cached Medicine News:Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3Health News:Orthopaedic Surgeon Dr. J. Hunt Udall Joins the Center for Pediatric Orthopaedics and Scoliosis as One of Few Trained Doctors to Perform Minimally Invasive Hip Arthroscopy 2Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 2Health News:Hospital Clinic Barcelona and Massachusetts General Hospital extract rectal mass through anus 3Health News:Hospital price transparancy laws in California fall short, study finds 2Health News:Exercise May Lead to a Smarter, More Successful You 2Health News:Exercise May Lead to a Smarter, More Successful You 3Health News:Hobby Lobby Selects Concentra to Open Health Center 2Health News:Hobby Lobby Selects Concentra to Open Health Center 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: